Health Canada drug identification number

DIN 01934333 — DEPO-MEDROL 40 MG

DEPO-MEDROL is a suspension of Methylprednisolone Acetate marketed by PFIZER CANADA ULC. The full Methylprednisolone Acetate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
01934333
Brand name
DEPO-MEDROL
Strength
40 MG
Dosage form
SUSPENSION
Route
INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL
Manufacturer
PFIZER CANADA ULC
Health Canada status
MARKETED
Drug class
Glucocorticoid (systemic corticosteroid); injectable depot suspension

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Methylprednisolone Acetate products

DINBrandStrengthFormManufacturerStatus
01934325 DEPO-MEDROL 20 MG SUSPENSION PFIZER CANADA ULC MARKETED
00030759 DEPO-MEDROL 40 MG SUSPENSION PFIZER CANADA ULC MARKETED
00030767 DEPO-MEDROL 80 MG SUSPENSION PFIZER CANADA ULC MARKETED
01934341 DEPO-MEDROL 80 MG SUSPENSION PFIZER CANADA ULC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.